AEQUUS PHARMACEUTICALS INC

TSXV : AQS

Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada. The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma. It also develops REV-0100 for the treatment of stargardt disease that is in pre-clinical trial. The company has a strategic collaboration with reVision for the development of a therapy for stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Information

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Type
Common Stock
Country
Canada

Price

CAD 0.02

Symbol

AQS

Type

Common Stock

Previous Close

:

0.01

52 Week Range

:

0.01 - 0.05

Volume

:

0.00

Average Volume

:

204,500.00

High

:

0.02

Low

:

0.02

Change

:

0.00

Percent change (%)

:

50.00

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...